Does Insurance Cover the Cost of Stent Replacement?

Vote: 1

The concept of stent replacement may seem unfamiliar in the medical field, as a stent is a tube-like mesh that is not replaced like a battery, but rather when the stent fails due to a medical phenomenon known as In-Stent Restenosis, where another stent is placed inside the original stent via drug-coated balloon angioplasty.


According to 2026, insurance companies will cover the cost of subsequent stent placement, as the recurrence of this blockage is regarded as a medical necessity that must be addressed to save lives. Below is the summary of the insurance companies' coverage policy.


Reasons for a Consistent Coverage Policy


For both private and government insurers (Medicare Part B or Private PPO/HMO), a blocked or clogged stent can be regarded as a serious issue. Requirements to have your services covered include:



  • Medical Necessity: The existence of medical proof of "recurring angina" or breathing problem.

  • Proof of Tests: The result of either stress test or angiography that shows 70% blockage of the stent.

  • Emergent Surgery: The stent is blocked by thrombosis.


What Will Be Specifically Covered?


In case you go through with the "replacement" surgery, commonly referred to as re-stenting, the following services will be specifically covered under your health care insurance in 2026:



  • Equipment: DES (Drug-Eluting Stent) or DCB (Drug-Coated Balloon)

  • Imaging: Intravascular Ultrasound (IVUS) or Optical Coherence Tomography (OCT) for the cause of the failed stent to be determined.

  • Hospitality: Re-stenting falls under Outpatient Surgery or 23-Hour Observation, which fall under outpatient procedures.


Possible Financial Constraints


All of the aforementioned services are covered under your health care insurance; however, there are financial constraints that might arise because this is a "repeat" surgery:






















Cost Factor



Typical 2026 Impact



Deductibles



Since heart issues are often chronic, many patients have already met their deductible for the year, but if not, this must be paid first.



Stent Caps



Some private or corporate policies have a "Cap" on the cost of the implant itself (e.g., they only pay up to $1,500 per stent).



Complexity Loading



Fixing an old stent is often more difficult than a first-time procedure. Some surgeons may bill higher "Complexity Codes," which could increase your 20% coinsurance share.



Specific Issues for 2026: Pre-Existing Conditions


In several international markets (e.g., India or UK private insurance), a prior stent implantation is considered a Pre-Existing Disease (PED).



  • Waiting Period: In case you have joined an insurance plan recently after having your first stent installed, then there will be a waiting period (usually between 2 and 4 years) before getting the coverage for the second surgery on the same blood vessel.

  • Arogya Sanjeevani Plan / Standard Plan: Most standard plans in 2026 offer reduced waiting periods for heart diseases; however, remember to refer to the "PED Clause" section in your insurance plan.


What Is Typically NOT Covered?


Optional Stent Upgrades: You cannot replace a functional "bare metal" stent with a new "drug-eluting" stent because it needs to be an upgrade for a blockage. Experimental "bio-absorbable" scaffolds: Some "dissolvable" stents are covered; others, however, especially if brand-new, may not be considered until they comply with your insurer's specific "Standard of Care" criteria.


Action Plan for Patients



  • Seek a Peer-to-Peer Call: Ask your cardiologist to arrange a "Peer-to-Peer" call with the insurance company's physician if they reject your claim for a second stent implantation.

  • Facility Verification: Make sure the cath lab where you have your cardiac work done is within your insurance network. Out-of-network facility fees for cardiac surgeries can run up in no time, sometimes over $20,000.

  • Post-Op Antiplatelet Drug Coverage Check: After a second stent implantation, you'll most probably require "Dual Antiplatelet Therapy" (for example, Brilinta/Effient). What "tier" will these medications be in the 2026 formulary?